<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">2842</id>
  <title>T3D2800</title>
  <common-name>Quinine</common-name>
  <description>Quinine is an alkaloid derived from the bark of the cinchona tree. It is used as an antimalarial drug, and is the active ingredient in extracts of the cinchona that have been used for that purpose since before 1633. Quinine is also a mild antipyretic and analgesic and has been used in common cold preparations for that purpose. It was used commonly and as a bitter and flavoring agent, and is still useful for the treatment of babesiosis. Quinine is also useful in some muscular disorders, especially nocturnal leg cramps and myotonia congenita, because of its direct effects on muscle membrane and sodium channels. The mechanisms of its antimalarial effects are not well understood.</description>
  <cas>130-95-0</cas>
  <pubchem-id>3034034</pubchem-id>
  <chemical-formula>C20H24N2O2</chemical-formula>
  <weight>324.183780</weight>
  <appearance>White powder.</appearance>
  <melting-point>57°C</melting-point>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility>500 mg/L (at 15°C)</solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure>Oral</route-of-exposure>
  <target nil="true"/>
  <mechanism-of-toxicity>The theorized mechanism of action for quinine and related anti-malarial drugs is that these drugs are toxic to the malaria parasite. Specifically, the drugs interfere with the parasite's ability to break down and digest hemoglobin. Consequently, the parasite starves and/or builds up toxic levels of partially degraded hemoglobin in itself. </mechanism-of-toxicity>
  <metabolism>Hepatic, over 80% metabolized by the liver.Route of Elimination: Quinine is eliminated primarily via hepatic biotransformation. Approximately 20% of quinine is excreted unchanged in urine.Half Life: Approximately 18 hours</metabolism>
  <toxicity></toxicity>
  <lethaldose nil="true"/>
  <carcinogenicity>No indication of carcinogenicity to humans (not listed by IARC).</carcinogenicity>
  <use-source>For the treatment of malaria and leg cramps. Used as an antipyretic (fever-reducing), antimalarial, analgesic (painkilling), and anti-inflammatory. It is also used as a flavor component of tonic water and bitter lemon.</use-source>
  <min-risk-level nil="true"/>
  <health-effects>It is usual for quinine in therapeutic doses to cause cinchonism; in rare cases, it may even cause death (usually by pulmonary edema). Quinine can worsen hemoglobinuria, myasthenia gravis and optic neuritis. It can cause paralysis if accidentally injected into a nerve, and is extremely toxic in overdose[Wikipedia]</health-effects>
  <symptoms>Fever, rarely hypotension. [wikipedia]</symptoms>
  <treatment nil="true"/>
  <created-at type="dateTime">2009-07-21T20:26:58Z</created-at>
  <updated-at type="dateTime">2026-05-14T16:39:44Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia>Quinine</wikipedia>
  <uniprot-id></uniprot-id>
  <kegg-compound-id>C06526</kegg-compound-id>
  <omim-id></omim-id>
  <chebi-id>15854</chebi-id>
  <biocyc-id>3-HYDROXYQUININE</biocyc-id>
  <ctd-id nil="true"/>
  <stitch-id>Quinine</stitch-id>
  <drugbank-id>DB00468</drugbank-id>
  <pdb-id></pdb-id>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>[H][C@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@H](O)C1=CC=NC2=CC=C(OC)C=C12</moldb-smiles>
  <moldb-formula>C20H24N2O2</moldb-formula>
  <moldb-inchi>InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19-,20+/m0/s1</moldb-inchi>
  <moldb-inchikey>LOUPRKONTZGTKE-WZBLMQSHSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">324.4168</moldb-average-mass>
  <moldb-mono-mass type="decimal">324.183778022</moldb-mono-mass>
  <origin>Exogenous</origin>
  <state>Solid</state>
  <logp>3.44</logp>
  <hmdb-id>HMDB14611</hmdb-id>
  <chembl-id>CHEMBL387326</chembl-id>
  <chemspider-id>84989</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference>&lt;p&gt;Tong Sun, Shawn Watson, Wei Lai, Stephan D. Parent, &amp;#8220;&lt;span class="caps"&gt;QUININE&lt;/span&gt; &lt;span class="caps"&gt;SULFATE&lt;/span&gt;/&lt;span class="caps"&gt;BISULFATE&lt;/span&gt; &lt;span class="caps"&gt;SOLID&lt;/span&gt; &lt;span class="caps"&gt;COMPLEX&lt;/span&gt;; &lt;span class="caps"&gt;METHODS&lt;/span&gt; OF &lt;span class="caps"&gt;MAKING&lt;/span&gt;; &lt;span class="caps"&gt;AND&lt;/span&gt; &lt;span class="caps"&gt;METHODS&lt;/span&gt; OF &lt;span class="caps"&gt;USE&lt;/span&gt; &lt;span class="caps"&gt;THEREOF&lt;/span&gt;.&amp;#8221; U.S. Patent US20090326005, issued December 31, 2009.&lt;/p&gt;</synthesis-reference>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM002202</chemdb-id>
  <dsstox-id>DTXSID0044280</dsstox-id>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00002397</susdat-id>
  <iupac>(R)-[(1S,2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol</iupac>
  <moldb-polar-surface-area>45.59</moldb-polar-surface-area>
  <moldb-refractivity>94.6936</moldb-refractivity>
  <moldb-polarizability>35.95718757326015</moldb-polarizability>
  <moldb-rotatable-bond-count>4</moldb-rotatable-bond-count>
  <moldb-acceptor-count>4</moldb-acceptor-count>
  <moldb-donor-count>1</moldb-donor-count>
  <moldb-pka-strongest-acidic>13.892048067691277</moldb-pka-strongest-acidic>
  <moldb-pka-strongest-basic>9.045547511829293</moldb-pka-strongest-basic>
  <moldb-physiological-charge>1</moldb-physiological-charge>
  <moldb-number-of-rings>4</moldb-number-of-rings>
  <moldb-alogps-logp>2.82</moldb-alogps-logp>
  <moldb-alogps-logs>-2.99</moldb-alogps-logs>
  <moldb-alogps-solubility>3.34e-01 g/l</moldb-alogps-solubility>
</compound>
